New growth hormone drug enters human testing for adults with deficiency

NCT ID NCT07551804

First seen Apr 29, 2026 · Last updated May 09, 2026 · Updated 1 time

Summary

This study tests a new drug called inpegsomatropin in 36 adults who lack enough growth hormone. Participants receive either the drug or a placebo to check safety and how the body processes it. The goal is to see if the drug can help restore normal hormone levels and improve body composition and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huashan Hospital, Fudan University

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking University First Hospital

    Beijing, China

    Contact

  • The First Affiliated Hospital of Henan University of Science and Technology

    Henan, China

    Contact

  • The Second Affiliated Hospital, Zhejiang University School of Medicine

    Zhejiang, China

    Contact

  • West China Hospital, Sichuan University

    Sichuan, China

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.